兔子先生

鈥濺esearch for a life without cancer鈥� is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts 鈥� whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.

The German Cancer Research Center (DKFZ) is seeking a

Postdoctoral Scientist for Artificial Intelligence in Oncology

Reference number: 2024-0357

• Heidelberg
• Fulltime
• Artificial Intelligence in Oncology

Within a project funded by the German Federal Ministry of Education and Research (BMBF) we are investigating the integration of magnetic resonance (MR) imaging and radiation therapy with ions.

To support the work on spatial genomics analyses of brain tumours, the Division of Artificial Intelligence in Oncology (headed by Prof. Dr. Moritz Gerstung) is seeking a postdoctoral scientist to join the team as soon as possible. These ongoing large-scale studies investigate the molecular mechanisms governing the microanatomical organisation across the spectrum of brain tumours [1].

The work is based on spatial transcriptomics, proteomics and genomics methods which provide a detailed molecular read out for millions of cells found in tumour tissues [2]. The lab develops and uses a range of data science and AI methods to distill biological knowledge from these large spatially resolved data sets and to extract biomarkers of disease progression [3,4]. This work is also closely related to efforts in digital pathology which provides the means to translate spatial genomics findings to a routine clinical setting [5,6].

References:
[1] Z. Seferbekova, A. Lomakin, L. R. Yates, and M. Gerstung, 鈥淪patial biology of cancer evolution,鈥� Nat. Rev. Genet., vol. 24, no. 5, pp. 295鈥�313, May 2023.
[2] A. Lomakin et al., 鈥淪patial genomics maps the structure, nature and evolution of cancer clones,鈥� Nature, vol. 611, no. 7936, pp. 594鈥�602, Nov. 2022.
[3] L. Marconato et al., 鈥淪patialData: an open and universal data framework for spatial omics,鈥� Nat. Methods, Mar. 2024, doi: 10.1038/s41592-024-02212-x. Available:

[4] V. Kleshchevnikov et al., 鈥淐ell2location maps fine-grained cell types in spatial transcriptomics,鈥� Nat. Biotechnol., Jan. 2022, doi: 10.1038/s41587-021-01139-4. Available:

[5] A. Shmatko, N. Ghaffari Laleh, M. Gerstung, and J. N. Kather, 鈥淎rtificial intelligence in histopathology: enhancing cancer research and clinical oncology,鈥� Nat Cancer, vol. 3, no. 9, pp. 1026鈥�1038, Sep. 2022.
[6] Y. Fu et al., 鈥淧an-cancer computational histopathology reveals mutations, tumor composition and prognosis,鈥� Nat Cancer, vol. 1, no. 8, pp. 800鈥�810, Aug. 2020.

Your Tasks

In this role, the candidate will engage in all relevant steps of the afore颅mentioned research projects. This includes experimental design, development of statistical and AI methods, compu颅tational analyses of large data sets, manuscript writing and reproducible documentation. You will work in close collaboration with AI specialists, compu颅tational biologists, clinicians and experimentalists. Due to the sizeable complexity within these projects, the candidate is encouraged to help shape these projects, explore their own areas of interest, and contribute new ideas and approaches to our research efforts.

Your Profile

• Master's and PhD degree in life or physical sciences with focus on bioinformatics
• Strong academic track record evidenced by peer-revied publications, preprints or other research outputs such as code repositories
• Deep understanding of data science methodologies
• Coding proficiency in Python, including PyTorch and other machine learning libraries
• Knowledge of cancer biology
• Affinity for collaborative work across discipline boundaries, international experience is an asset
• Proficiency in spoken and written English

Contact:
Eileen Haage
Phone: +49 6221 42-4522

The position is initially limited to 2 years with the possibility of prolongation.

Are you interested?

Then become part of the DKFZ and join us in contributing to a life without cancer!


We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.

Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.